Careteq Achieves Maiden EBITDA Profit and Reports Strong Half-Year Results

Careteq Ltd. ( (AU:CTQ) ) just unveiled an announcement.

Careteq Limited has announced its half-year results for the period ending December 31, 2024, achieving a maiden EBITDA profit of $0.2 million from continuing operations, marking a significant turnaround from a loss in the previous corresponding period. The company has seen a 15.5% increase in group revenue and a 275.2% rise in normalized group EBITDA. Strategic transactions, including divesting the Sofihub business and acquiring the remaining stake in Embedded Health Solutions (EHS), have streamlined operations and enhanced focus on medication management and clinical governance. The integration of EHS and HMR Referrals is expected to drive further operational efficiencies and expand service offerings, positioning Careteq for continued growth and positive financial performance in FY25.

More about Careteq Ltd.

Careteq Limited is a clinical healthtech company that specializes in innovative medication management and clinical governance solutions. The company focuses on providing integrated solutions across residential aged care, home care, and disability sectors.

YTD Price Performance: 40.0%

Average Trading Volume: 402,286

Technical Sentiment Consensus Rating: Strong Buy

Find detailed analytics on CTQ stock on TipRanks’ Stock Analysis page.